Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Sayuri Akiyoshi

2PUBLICATIONS

32CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Feb 03, 2026

Optimizing Antiemetic Support in Anthracycline-Based Chemotherapy for Early Breast Cancer: Protocol for a Prospective Observational Study of Four-Drug Antiemetic Therapy Including Fosnetupitant and Olanzapine.

Ayako Higuchi, Yumiko Koi, Tomoaki Eto

|Nov 29, 2022

MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer.

Nami Yamashita, Yoshihiro Morimoto, Atsushi Fushimi

Pageof 1

Frequent Collaborators

1 joint publications

Nami Yamashita

1 joint publications

Yoshihiro Morimoto

1 joint publications

Atsushi Fushimi

1 joint publications

Rehan Ahmad

1 joint publications

Atrayee Bhattacharya

1 joint publications

Tatsuaki Daimon

1 joint publications

Naoki Haratake

1 joint publications

Yuka Inoue

1 joint publications

Satoshi Ishikawa

1 joint publications

Masaaki Yamamoto

Frequent Collaborators

1 joint publications

Nami Yamashita

1 joint publications

Yoshihiro Morimoto

1 joint publications

Atsushi Fushimi

1 joint publications

Rehan Ahmad

Top Related Videos

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on : Mar 20, 2020

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos

Top Related Videos

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on : Mar 20, 2020

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos